7-Bromo-[1,3]oxazolo[4,5-b]pyridine, 95+%, 5g

N-(1',2-Dihydroxy-[1,2'-binaphthalen]-4'-yl)-4-methoxybenzenesulfonamide, 98%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-cyclohexylbutanoic acid, 97%, 25g

2-formylphenyl dimethylcarbamate, 5g

[1,4'-Bipyridin]-1-ium chloride hydrochloride, 95.0%, 25g

3-(4-Bromo-phenyl)-1H-pyrazole-4-carbaldehyde, 1g

trans-4-(Benzyloxycarbonylamino)cyclohexanecarbaldehyde, 97.0%, 250mg

8-Bromo-6-methylimidazo[1,2-a]pyridine-3-carbaldehyde, 98%, 1g

1-Methyl-4-nitro-3-propyl-1H-pyrazole-5-carboxylic acid, 95.0%, 25g

4-(((2,2-Dimethyl-4,6-dioxo-1,3-dioxan-5-ylidene)methyl)amino)benzonitrile, 95+%, 250mg

5-Amino-2-fluorobenzotrifluoride, 99.0%, 500g

Methyl 2-(chloromethyl)benzo[d]oxazole-5-carboxylate, 95.0%, 500mg

GC capillary column ROTI®Cap-5 MS, 50 m, 0.20 mm, 0.20 µm, 1 Piece(s)